Skip to Content

Pop-Up COVID-19 Funding Opportunity

Image of COVID-19


Coronaviruses are a diverse family of viruses that cause a range of disease in humans and animals, and there are currently no approved coronavirus vaccines or therapeutics. In January 2020, a novel coronavirus, COVID-19, was identified as the causative agent of an outbreak of viral pneumonia centered around Wuhan, China. Current information regarding confirmed cases is changing daily and can be found on the Centers for Disease Control and Prevention website. Transmission characteristics and the associated morbidity and mortality are not completely understood, but there is clear evidence of human-to-human transmission. Many other aspects of the disease are also poorly understood, resulting in an urgent public health need to better understand COVID-19. WVCTSI is accepting applications for clinical and translational research focusing on COVID-19.

Applications Accepted on Rolling Basis until April 30, 2020

Award Project Period

The scope of the proposed project should determine the project period. The maximum project period is twelve (12) months.


The budget is limited to a maximum of $30,000 in total direct costs for twelve (12) months. Please see Application Instructions for detailed allowable expenses.

Eligibility Information

  • Principal Investigator (PI) must hold a faculty appointment or equivalent at the time the award is announced. Appointments can be held at CAMC Institute/WVU Charleston, Marshall University, West Virginia School of Osteopathic Medicine, and West Virginia University. Individuals holding postdoctoral fellowships or other positions that lack independent status are not eligible to lead pilot projects. VA investigators may apply and receive CTSI services, however, regulations do not permit CTSI to fund federal agencies.
  • Note that Marshall University faculty members must hold an appointment in either the School of Medicine or the School of Pharmacy. Other Schools and Colleges at Marshall University are NOT currently eligible for WVCTSI Pilot grants.



Meghan Reeves, MPH- Assistant Director of Investigator Development